InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
+0.2%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Stahler Rachel A, Directeur Exécutif. Officer active across 2 companies, notably Neogenomics INC. In total, 16 filings have been logged. History available since 2 June 2021. The latest transaction was disclosed on 31 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations16 total
8,200 shares0Common StockSEC:0001821825-25-000016:0
14,037 shares0Common StockSEC:0001679854-25-000002:0
3,594 shares0Common StockSEC:0001821825-24-000101:0
3,049 shares0Common StockSEC:0001821825-24-000057:0
3,578 shares0Common StockSEC:0001821825-24-000048:0
12,117 sharesCommon StockSEC:0001821825-24-000012:0
12,895 sharesCommon StockSEC:0001209191-23-045068:0
3,046 sharesCommon StockSEC:0001209191-23-028104:0
3,578 shares0Common StockSEC:0001209191-23-023085:0
12,890 sharesCommon StockSEC:0001104659-22-088175:0
15,556 shares0Common StockSEC:0001077183-22-000109:0
3,046 sharesCommon StockSEC:0001104659-22-056632:0
12,890 shares@ US$28.630.0089% mcap50.0% of flowCommon StockSEC:0000899243-21-032180:0
12,890 shares@ US$28.6350.0% of flowCommon StockSEC:0000899243-21-032180
3,081 shares0Common StockSEC:0001077183-21-000159:0
3,081 shares0Common StockSEC:0001077183-21-000159
16 of 16 declarations
About Stahler Rachel A
Rachel A. Stahler is a Board Member and Chief Information Officer at Neogenomics Inc and Organon & Co. She is responsible for managing information systems and developing technology strategies. Her expertise in information technology management is essential for supporting the company's growth.
